ES482483A1 - Novel taurine derivatives - Google Patents

Novel taurine derivatives

Info

Publication number
ES482483A1
ES482483A1 ES482483A ES482483A ES482483A1 ES 482483 A1 ES482483 A1 ES 482483A1 ES 482483 A ES482483 A ES 482483A ES 482483 A ES482483 A ES 482483A ES 482483 A1 ES482483 A1 ES 482483A1
Authority
ES
Spain
Prior art keywords
taurine derivatives
novel
novel taurine
derivatives
ch2ch2or
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES482483A
Other languages
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratorio Chimico Farmaceutico Causyth SpA
Original Assignee
Laboratorio Chimico Farmaceutico Causyth SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratorio Chimico Farmaceutico Causyth SpA filed Critical Laboratorio Chimico Farmaceutico Causyth SpA
Publication of ES482483A1 publication Critical patent/ES482483A1/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79Acids; Esters
    • C07D213/80Acids; Esters in position 3
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81Amides; Imides
    • C07D213/82Amides; Imides in position 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pyridine Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Novel taurine derivatives of general formula (I> < IMAGE > (wherein R<1> is nicotinoyl, 3,4,5- trimethoxybenzoyl or acetylsalicyloyl and R<2> is R<1> or -CH2CH2OR<1>) have antilipemic and choleretic activities, and are made by acylation methods.
ES482483A 1978-06-15 1979-07-13 Novel taurine derivatives Expired ES482483A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT24587/78A IT1096662B (en) 1978-06-15 1978-06-15 TAURINIC DERIVATIVES FOR ANTI-LIPEMIC AND CHOLERETIC ACTIVITIES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM

Publications (1)

Publication Number Publication Date
ES482483A1 true ES482483A1 (en) 1980-04-16

Family

ID=11214073

Family Applications (3)

Application Number Title Priority Date Filing Date
ES476812A Expired ES476812A1 (en) 1978-06-15 1979-01-12 Novel taurine derivatives
ES482484A Expired ES482484A1 (en) 1978-06-15 1979-07-13 Novel taurine derivatives
ES482483A Expired ES482483A1 (en) 1978-06-15 1979-07-13 Novel taurine derivatives

Family Applications Before (2)

Application Number Title Priority Date Filing Date
ES476812A Expired ES476812A1 (en) 1978-06-15 1979-01-12 Novel taurine derivatives
ES482484A Expired ES482484A1 (en) 1978-06-15 1979-07-13 Novel taurine derivatives

Country Status (9)

Country Link
JP (2) JPS5943942B2 (en)
BE (1) BE876969A (en)
DE (1) DE2901046C3 (en)
ES (3) ES476812A1 (en)
FR (2) FR2465717A1 (en)
GB (1) GB2023586B (en)
IT (1) IT1096662B (en)
LU (1) LU81379A1 (en)
NL (1) NL7904644A (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1126575B (en) * 1979-12-07 1986-05-21 Causyth Chim Farm COMPOUND WITH ANTI-INFLAMMATORY, ANALGESIC AND ANTI-PIRETIC ACTIVITY, PROCESS FOR ITS PREPARATION, AND RELATED PHARMACEUTICAL COMPOSITIONS

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB586453A (en) * 1944-08-01 1947-03-19 Ward Blenkinsop & Co Ltd Process for the production of derivatives of nicotinic acid
FR920312A (en) * 1944-08-01 1947-04-03 Ward Process for the preparation of nicotic acid derivatives
CH520697A (en) * 1970-03-03 1972-03-31 Sopharma Sa Process for the preparation of a nicotinic acid ester-amide

Also Published As

Publication number Publication date
NL7904644A (en) 1979-12-18
DE2901046A1 (en) 1979-12-20
ES476812A1 (en) 1979-12-16
JPS554381A (en) 1980-01-12
LU81379A1 (en) 1979-09-12
DE2901046C3 (en) 1982-05-06
JPS5943942B2 (en) 1984-10-25
FR2511365A1 (en) 1983-02-18
GB2023586A (en) 1980-01-03
IT1096662B (en) 1985-08-26
DE2901046B2 (en) 1981-07-16
IT7824587A0 (en) 1978-06-15
ES482484A1 (en) 1980-04-01
FR2511365B1 (en) 1985-03-15
FR2465717A1 (en) 1981-03-27
BE876969A (en) 1979-10-01
JPS6133171A (en) 1986-02-17
GB2023586B (en) 1982-08-04

Similar Documents

Publication Publication Date Title
TW341573B (en) New erythromycin derivatives, their preparation process and their use as medicaments
AR223169A1 (en) DERIVATIVES OF ((PIRIMIDIN OR 1,3,5-TRIAZIN-2-IL) -AMINO-CARBONYL) -PHENYL SULFAMATE
ES8300785A1 (en) Androstene 17 alpha -carbonate 17 beta -carboxylates (and carbothioates)
EP0287959A1 (en) p-Phenoxy--phenoxymethyl substituted five membered heteroaromatics.
JPS5297950A (en) Chalconeether derivatives
JPS5432460A (en) Cycloalkylidenemethylphenylacetic acid derivative and their preparation
BR8500851A (en) PROCESS TO PRODUCE A BENZOYLUREA DERIVATIVE AND PROCESS TO PRODUCE AN INSECTICIDE AND / OR OVICIDE COMPOSITION
SE7910072L (en) PYRROLO- OR PYRIDO (2,1-C) (1,4) TIAZINES OR -TIAZEPINES
ES476812A1 (en) Novel taurine derivatives
IE781193L (en) Nitroso-ureas
ES466794A1 (en) Antiinflammatory 4,5-dicyclic-2-(substituted thio)-imidazoles and their corresponding sulphoxides and sulphones
JPS5430183A (en) 3,4-dihydrocarbostyril derivative
NO792126L (en) CARBAZOLE DERIVATIVES.
ES467886A1 (en) 3 beta -Hydroxy-18 beta -olean-9-en-30-oic acids
JPS5419987A (en) Pyridazinone derivative and its preparation
ES8603396A1 (en) Benzoylurea derivatives and intermediates.
IE45258L (en) Tetrahydronaphthalenes
JPS52130822A (en) Tetrachloronaphthalic imide derivative and its production
JPS52100473A (en) Novel azimidebenzamide derivative and its production
JPS5427578A (en) 1-carboxyalkylcarbamoyl-5-fluorouracil derivatives and their preparation
JPS5416466A (en) Novel 3-hydroxypyrrolldine-3-carboxylic derivative
JPS52106848A (en) Cyclopropenone and cyclopenthione derivatives and their preparation
MY104804A (en) Process for preparing optically active isomers of 6-substituted purinyl piperazine derivatives
JPS5414961A (en) Novel 3-hydroxyazetidine-3-carboxylic derivative
JPS5387330A (en) Novel thiohydroxymate derivative, its preparation and bactericideand herbicide containing the same